Park Medi World Limited told the exchanges on 5 June 2026 that the board of its wholly owned subsidiary, Aggarwal Hospital and Research Services Private Limited, has approved the divestment of its 55% shareholding in Devina Derma Private Limited for about Rs 0.06 crore.
On completion, Devina Derma will cease to be a subsidiary of Aggarwal Hospital and, in turn, of Park Medi World. The transaction value is small relative to the group, and the company disclosed it under SEBI listing rules.
Park Medi World is a healthcare company with a market value of about Rs 2,500 crore, trading at roughly 9 times earnings. Its shares eased about 1.3% on the day to around Rs 282.
The details are taken from Park Medi World’s filing with NSE and BSE dated 5 June 2026. This note is for information only and is not investment advice.